Kairos Pharma, Ltd.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2022 | — | — | $437.0K |
| Sep 2023 | — | — | $99.0K |
| Dec 2023 | $3.0M | $965.0K | $93.0K |
| Mar 2024 | — | — | $40.0K |
| Jun 2024 | — | — | $21.0K |
| Sep 2024 | $1.7M | $5.0M | $3.2M |
| Dec 2024 | $992.0K | $5.8M | $1.3M |
| Mar 2025 | $805.0K | $7.9M | $3.6M |
| Jun 2025 | $676.0K | $6.7M | $3.0M |
| Sep 2025 | $402.0K | $8.1M | $5.6M |
| Dec 2025 | $199.0K | $6.5M | $4.5M |
| Mar 2026 | $431.0K | $5.7M | $3.7M |
| Jun 2026 | $265.0K | $4.5M | $2.6M |